Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...

Juno Therapeutics could be set for a remarkable comeback in CAR-T therapy, after encouraging trial data on a new candidate suggests it could be prove to be the best in class. The Seattle-based biotech ...

We're now in the fall season of 2025's new anime, but the industry is showing no signs of slowing down. Fresh off Demon Slayer and Chainsaw Man's twin successes in theaters, we've got plenty of TV ...